Global Health Initiative
Envisioned by Cognigen Corporation, a Simulations Plus (Nasdaq:SLP) company, in 2003, the Pharma of the FutureSM (PoF) program was conceived as a research and training initiative to design and implement the workflows and computer systems required to support modeling and simulation (M&S) activities.Read On
The Worst Job In Pharma
Being the Team Leader of an R&D team might not be down at the level of some of the jobs on Mike Rowe’s Dirty Jobs on TV’s Discovery Channel, but I nominate it as the worst job in Pharma.Read On
The pluses and minuses of groupthink
Susan Cain recently wrote about the advantages and limitations of team work versus going it alone in the New York Times Sunday Review.Read On
Impressions of Monet.
I recently had the occasion to visit the Monet exhibition at the Grand Palais in Paris. Several things about this exhibit blew me away.Read On
Kerfuffle! (pt 2)
Chapter 2 of 3. Need to catch up? Read the previous post in the series.Read On
What’s Next for Fit-for-Purpose (F4P) Models?
Taking fit-for-purpose (F4P) models to the next level – Collaboration between scientists and software designersRead On
History of Pharma of the Future
Pharmacometric modeling and simulation has moved from its infancy as a novel way of approaching the analysis of clinical pharmacokinetic data to become an invaluable tool in pharmaceutical and biotechnology research and development.Read On
Excellence Is a Team Sport
Scientific excellence–asking the right question, then designing and conducting a valid study that answers that question and influences future research–is widely accepted as a benchmark for success in research. However, excellence of a more complicated sort is required in Pharma research. For example, excellence in pharmacometric modeling and simulation has to encompass 3 types of excellence: strategic, operational, and technical.Read On
Thinking about thinking.
In a podcast called Thinking About Thinking, three eminent scientists discuss the ways humans think. All three have interesting and useful insights. I recommend this podcast to anyone responsible for managing Pharma R&D teams or for anyone looking for new ways to improve team performance, especially in knowledge-intensive research efforts.Read On
Learning to be an architect of ideas.
I have long been addicted to The New York Times Book Review. It is not that I am a writer groupie as much as I find it fascinating to read about how a book came about.Read On